These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8830729)

  • 1. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
    Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
    Gutensohn K; Weh HJ; Walter TA; Hossfeld DK
    Ann Hematol; 1992 Aug; 65(2):88-90. PubMed ID: 1511063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
    Smadja NV; Louvet C; Isnard F; Dutel JL; Grange MJ; Varette C; Krulik M
    Br J Haematol; 1995 Jul; 90(3):619-24. PubMed ID: 7647003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
    Facon T; Lai JL; Nataf E; Preudhomme C; Zandecki M; Hammad M; Wattel E; Jouet JP; Bauters F
    Br J Haematol; 1993 Aug; 84(4):743-5. PubMed ID: 8217836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic study of multiple myeloma].
    Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
    Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of SCF, IL-6, IL-3, and GM-CSF increases the mitotic index in short term bone marrow cultures from acute promyelocytic leukemia (APL) patients.
    Williams B; Allan DJ
    Cancer Genet Cytogenet; 1996 Oct; 91(1):77-81. PubMed ID: 8908173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
    Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
    Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human IL-3 on the mitotic index and karyotype of hemopoietic cells.
    Kerim S; Rege-Cambrin G; Scaravaglio P; Carozzi F; Saglio G; Aglietta M
    Cancer Genet Cytogenet; 1991 Sep; 55(2):235-41. PubMed ID: 1933826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
    Hernández JM; Gutiérrez NC; Almeida J; García JL; Sánchez MA; Mateo G; Ríos A; San Miguel JF
    Br J Haematol; 1998 Oct; 103(1):163-7. PubMed ID: 9792304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells.
    Gmidène A; Avet-Loiseau H; Sennana H; Ben Abdallah I; Khlif A; Meddeb B; Elloumi M; Saad A
    Cytogenet Genome Res; 2012; 136(1):44-9. PubMed ID: 22188899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of myelodysplastic syndrome marrow progenitor cells to stimualtion with cytokine combinations in a stroma-free long-term culture system.
    Soligo DA; Campiglio S; Servida F; Bossolasco P; Romitti L; Cortelezzi A; Lambertenghi Deliliers G
    Br J Haematol; 1996 Mar; 92(3):548-58. PubMed ID: 8616015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.
    Mugneret F; Sidaner I; Favre B; Manone L; Maynadié M; Caillot D; Solary E
    Leukemia; 1995 Feb; 9(2):277-81. PubMed ID: 7869764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotype in multiple myeloma and plasma cell leukaemia.
    Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
    Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicolor spectral karyotyping in multiple myeloma.
    Sawyer JR
    Methods Mol Med; 2005; 113():49-58. PubMed ID: 15968094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.